In pathological conditions in which the integrity of the blood brain barrier has been compromised, as in the case for AD, Igs may pass through the blood brain barrier, and thereby mediate neurotoxicity and inflammation [53]. This evidence concerns the gene CUBN and Alzheimer disease.